Treatment strategy changes for inflammatory bowel diseases in biologic era: results from a multicenter cohort in Japan, Far East 1000

Many molecular targeted agents, including biologics, have emerged for inflammatory bowel diseases (IBD), but their high prices have prevented their widespread use. This study aimed to reveal the changes in patient characteristics and the therapeutic strategies of IBD before and after the implementat...

Descripción completa

Detalles Bibliográficos
Autores principales: Taida, Takashi, Ohta, Yuki, Kato, Jun, Ogasawara, Sadahisa, Ohyama, Yuhei, Mamiya, Yukiyo, Nakazawa, Hayato, Horio, Ryosuke, Goto, Chihiro, Takahashi, Satsuki, Kurosugi, Akane, Sonoda, Michiko, Shiratori, Wataru, Kaneko, Tatsuya, Yokoyama, Yuya, Akizue, Naoki, Iino, Yotaro, Kumagai, Junichiro, Ishigami, Hideaki, Koseki, Hirotaka, Okimoto, Kenichiro, Saito, Keiko, Saito, Masaya, Matsumura, Tomoaki, Nakagawa, Tomoo, Okabe, Shinichiro, Saito, Hirofumi, Kato, Kazuki, Uehara, Hirotsugu, Mizumoto, Hideaki, Koma, Yoshihiro, Azemoto, Ryosaku, Ito, Kenji, Kamezaki, Hidehiro, Mandai, Yoshifumi, Masuya, Yoshio, Fukuda, Yoshihiro, Kitsukawa, Yoshio, Shimura, Haruhisa, Tsuyuguchi, Toshio, Kato, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442357/
https://www.ncbi.nlm.nih.gov/pubmed/37604846
http://dx.doi.org/10.1038/s41598-023-40624-5

Ejemplares similares

Ejemplares similares